JD1 Forget the options. What about the huge cash bonus' they've been giving out?
I wonder how Stason is doing. We license TNT to a company who has create a spin off to fulfill the agreement. Brilliant. Hey Running Mary, any other great deals you're closing?
2011, Stason Animal Health (SAH) was formed In 2011, Stason Animal Health (SAH) was formed and currently offers a vertically integrated, value-added platform for drug development, manufacturing, distribution, marketing, and sales of pet health products into veterinary hospitals and retail drug stores.
September 2011, US companies team up to offer US Biologics and Biosimilar expertise to Asian manufacturers and drug developers
16 December 2010 Stason and Lonza Sign Agreement to License the GS Gene Expression System™ to Develop and Manufacture TNT Antibodies
March 10, 2010 Unilife and Stason Pharmaceuticals Sign Asian Distribution Agreement for the Unitract™ 1mL Safety Syringe
May 03, 2010 08:00 ET Peregrine Pharmaceuticals and Stason Pharmaceuticals to Pursue Tumor Necrosis Therapy Development Pact in Asia
What a bunch of BS
Stasons core generic therapeutic categories include oncology, CNS, cardiovascular and dermatologic indications. Expanding our generic product portfolio, Stason is geared to file 4-5 or more ANDA’s per year in the areas of oncology and CNS.
In May 2009, Stason entered into an exclusive license agreement with a US based company to identify Asian partners for an OB/GYN product currently under development in North America. The NDA is being prepared to be submitted late 2010.
Publications
Aqueous Enteric Coating Factorial Design for Wet Granulation API Degradation
Events & Tradeshows
CPhI Worldwide Annual Meeting October 5 - 7, 2010 Paris Nord Villepinte Exhibition Center Paris, France Booth Number: NAP045 - North American Pavilion in Hall 6
Market Data 
Markets 
AI
